2022 Medicinal Chemistry Reviews, pages 447-471
THE RISE, FALL, AND FUTURE PROMISE OF IDO1 INHIBITORS FOR IMMUNO-ONCOLOGY
Emily C Cherney
1
,
DAVID K. WILLIAMS
1
,
Liping Zhang
1
,
Susheel J Nara
2
1
Bristol Myers Squibb, Lawrenceville, New Jersey, U.S.A.
|
2
Biocon BMS R&D Center, Bengaluru, India
|
Publication type: Book Chapter
Publication date: 2023-11-16
Journal:
2022 Medicinal Chemistry Reviews
SJR: —
CiteScore: —
Impact factor: —
ISSN: 25759183, 25759175
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.